# Invesco Health Care S&P US Select Sector UCITS ETF (XLVP) **Page:** https://fundology.uk/fund/xlvp · ISIN IE00B3WMTH43 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, XLVP (Invesco Health Care S&P US Select Sector UCITS ETF, ISIN IE00B3WMTH43) closed at £708.45 on the London Stock Exchange. Its ongoing charge is 0.14% a year (about £14 on £10,000). Over the five years to 13/11/2026 its total return was +52.6%, or +19.1% after UK CPIH inflation. ## Summary Invesco Health Care S&P US Select Sector UCITS ETF is an exchange-traded fund (ETF) from Invesco, launched in 2009. It tracks the S&P Select Sector Capped 20% Health Care Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.14% a year — about £14 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£708.45** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | XLVP | | ISIN | IE00B3WMTH43 | | Also listed as | XLVS (London Stock Exchange, US dollars) | | Category | Healthcare | | Type | ETF | | Provider | Invesco | | Tracks | S&P Select Sector Capped 20% Health Care Index | | Income | Accumulating | | Ongoing charge | 0.14% a year (£14 per £10,000) | | Fund size | £486m | | Launched | 2009 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 01/12/2009 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +25.90% | +21.44% | income reinvested | | 3 years | +43.34% | +29.50% | income reinvested | | 5 years | +52.59% | +19.10% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund): 2022 +9.0%, 2023 −3.9%, 2024 +5.6%, 2025 +4.3%; 2026 to 13/11/2026 +25.2%. Returns of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +20.9%; to 30/09/2025: −5.1%; to 30/09/2024: +9.8%; to 30/09/2023: −2.9%; to 30/09/2022: +20.3%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | +9.0% | -0.2% | Price | | 2023 | -3.9% | -7.7% | Price | | 2024 | +5.6% | +2.0% | Price | | 2025 | +4.3% | +0.7% | Price | | 2026 to 13/11/2026 | +25.2% | +21.2% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 17.03% | -10.72% | | 3 years | 14.56% | -19.00% | | 5 years | 14.18% | -19.00% | ## Largest fall Volatility of Invesco Health Care S&P US Select Sector UCITS ETF in pounds, annualised from weekly returns to 13/11/2026: 17.0% over 1 year, 14.6% over 3 years, 14.2% over 5 years. Largest fall in the price of Invesco Health Care S&P US Select Sector UCITS ETF since November 2021, in pounds: −19.0% from 31/01/2025 to 23/05/2025. The lowest 12-month return of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund) since January 2021 was −16.8% (12 months to 08/08/2025); the highest was +30.0% (12 months to 08/04/2022). On 13/11/2026 the price of Invesco Health Care S&P US Select Sector UCITS ETF was at its highest weekly close since November 2021, in pounds. ## Charges compared with similar funds Ongoing charge of Invesco Health Care S&P US Select Sector UCITS ETF 0.14% a year. Compared on 14/11/2026, 27 of the 28 other healthcare funds charge more, 0 the same and 1 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.14%** per year (as of 13/11/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds As of 30/09/2026, XLVP holds 60 positions, according to its published holdings. The largest is Eli Lilly at 15.20% of the fund; the ten largest make up 60.9%. ### Top holdings Largest positions (as of 30/09/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | Eli Lilly | [LLY](https://fundology.uk/stock/LLY) | 15.20% | | 2 | Johnson & Johnson | [JNJ](https://fundology.uk/stock/JNJ) | 10.50% | | 3 | AbbVie | [ABBV](https://fundology.uk/stock/ABBV) | 7.60% | | 4 | Merck | [MRK](https://fundology.uk/stock/MRK) | 5.90% | | 5 | UnitedHealth Group | [UNH](https://fundology.uk/stock/UNH) | 5.40% | | 6 | Thermo Fisher Scientific | [TMO](https://fundology.uk/stock/TMO) | 4.10% | | 7 | Amgen | [AMGN](https://fundology.uk/stock/AMGN) | 3.70% | | 8 | Gilead Sciences | [GILD](https://fundology.uk/stock/GILD) | 3.00% | | 9 | Abbott Laboratories | [ABT](https://fundology.uk/stock/ABT) | 2.80% | | 10 | Pfizer | [PFE](https://fundology.uk/stock/PFE) | 2.70% | ## Where it invests Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed. ### By country Added up from the fund’s published holdings, as of 23/09/2026. | Country | Weight | |---|---| | United States | 97.8% | | Ireland | 2.2% | All 60 holdings: https://fundology.uk/fund/xlvp/holdings ## Questions people ask **What is the ongoing charge of XLVP?** The ongoing charge of XLVP is 0.14% a year — about £14 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco Health Care S&P US Select Sector UCITS ETF 0.14% a year. Compared on 14/11/2026, 27 of the 28 other healthcare funds charge more, 0 the same and 1 less (share classes counted once). **What does XLVP track?** XLVP tracks the S&P Select Sector Capped 20% Health Care Index. **Is XLVP accumulating or distributing?** XLVP is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of XLVP?** The ISIN of XLVP is IE00B3WMTH43. An ISIN identifies one exact share class of a fund; XLVP is its ticker on the London Stock Exchange. The same share class is also listed as XLVS (London Stock Exchange, US dollars). **What does XLVP hold?** As of 30/09/2026, XLVP holds 60 positions, according to its published holdings. The largest is Eli Lilly at 15.20% of the fund; the ten largest make up 60.9%. Its ten largest holdings are Eli Lilly (15.20%), Johnson & Johnson (10.50%), AbbVie (7.60%), Merck (5.90%), UnitedHealth Group (5.40%), Thermo Fisher Scientific (4.10%), Amgen (3.70%), Gilead Sciences (3.00%), Abbott Laboratories (2.80%) and Pfizer (2.70%). **What were XLVP’s returns in each of the last five years?** Calendar-year returns of XLVP in pounds (price, with income reinvested in the fund): 2022 +9.0%, 2023 −3.9%, 2024 +5.6%, 2025 +4.3%; 2026 to 13/11/2026 +25.2%. Past performance is not a guide to future returns. **How has XLVP done after inflation?** Over the five years to 13/11/2026 XLVP’s total return was +52.6%, or +19.1% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.